JWPHARMA(1P) revenue for the last year amounted to 749.00 B KRW, the most of which — 748.53 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 684.35 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought JWPHARMA(1P) 748.53 B KRW, and the year before that — 684.35 B KRW.